Pictet Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$814K Buy
2,920
+340
+13% +$97.9K ﹤0.01% 1203
2025
Q4
$782K Buy
2,580
+160
+7% +$49.9K ﹤0.01% 1224
2025
Q3
$679K Sell
2,420
-340
-12% -$92.5K ﹤0.01% 1237
2025
Q2
$666K Sell
2,760
-11,572
-81% -$2.74M ﹤0.01% 1233
2025
Q1
$3.49M Buy
14,332
+1,214
+9% +$365K ﹤0.01% 843
2024
Q4
$4.31M Buy
13,118
+91
+0.7% +$30.9K ﹤0.01% 833
2024
Q3
$4.36M Sell
13,027
-1,774
-12% -$563K ﹤0.01% 819
2024
Q2
$4.04M Buy
14,801
+1,320
+10% +$384K ﹤0.01% 814
2024
Q1
$4.66M Sell
13,481
-1,138
-8% -$374K 0.01% 795
2023
Q4
$4.72M Buy
14,619
+4,284
+41% +$1.34M 0.01% 804
2023
Q3
$3.7M Buy
+10,335
New +$3.99M ﹤0.01% 830

Other funds holding BIO